Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Deepak

Balak

,

MD, PhD, MSc

Dermatologist
Leiden University Medical Center
Leiden
,
Netherlands
2019 Fellow
IPC Jr. Councilor
Dr. Balak is a dermatologist at the Department of Dermatology of the Leiden University Medical Center (Leiden, Netherlands), where he combines patient care with teaching responsibilities and research. His clinical interests are centered on the impact and management of inflammatory and autoimmune diseases. His scientific interests include translational medicine, clinical drug development, and evaluation in the field of chronic immune-mediated inflammatory skin diseases, such as psoriasis. As a 2019 IPC Fellow, he studied with Dr. Alice Gottlieb at the Mount Sinai Hospital in New York, New York, and attended the European Academy of Dermatology and Venereology (EADV) Congress. While in New York, he observed Dr. Gottlieb’s clinics with complex and therapy-recalcitrant cases of psoriasis and psoriatic arthritis. He joined residents in didactics programs and ground rounds and participated in ongoing psoriasis-research projects (IDEOM).
Last Updated:
06/29/2025

Areas of Interest

Clinical management of psoriasis; Value-based healthcare; Clinical pharmacology; Drug development

Languages Spoken

Dutch, English

Involvement with Other Organization(s)

Dr. Balak is a medical advisor for the Dutch psoriasis patient association (Psoriasispatiënten Nederland).

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026